Ghrelin: A New Incretin Enhancer Therapy?

被引：6

作者：

DeMarco, Vincent G. ^{[1
,2
,3
]}

Sowers, James R. ^{[1
,2
,3
,4
]}

机构：

[1] Univ Missouri, Sch Med, Dept Med, Columbia, MO 65212 USA

[2] Univ Missouri, Sch Med, Dept Med Pharmacol & Physiol, Columbia, MO USA

[3] Univ Missouri, Sch Med, Diabet & Cardiovasc Ctr, Columbia, MO USA

[4] Harry S Truman VA Med Ctr, Columbia, MO USA

来源：

DIABETES | 2015年 / 64卷 / 05期

关键词：

SYSTEM;

D O I：

10.2337/db14-1871

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1500 / 1502

页数：3

共 11 条

[1] Pleiotropic effects of the dipeptidylpeptidase-4 inhibitors on the cardiovascular system [J].

Aroor, Annayya R. ;

Sowers, James R. ;

Jia, Guanghong ;

DeMarco, Vincent G. .

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2014, 307 (04) :H477-H492

[2] GLP-1-Based Strategies: A Physiological Analysis of Differential Mode of Action [J].

Burcelin, Remy ;

Gourdy, Pierre ;

Dalle, Stephane .

PHYSIOLOGY, 2014, 29 (02) :108-121

[3] The role of gut hormones in glucose homeostasis [J].

Drucker, Daniel J. .

JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (01) :24-32

[4] Commentary: What can we learn from the continuing regulatory focus on the thiazolidinediones? [J].

Freemantle, Nick .

BRITISH MEDICAL JOURNAL, 2010, 341

[5] Ghrelin Is a Novel Regulator of GLP-1 Secretion [J].

Gagnon, Jeffrey ;

Baggio, Laurie L. ;

Drucker, Daniel J. ;

Brubaker, Patricia L. .

DIABETES, 2015, 64 (05) :1513-1521

[6]

Kojima Masayasu, 2008, V46, P89, DOI 10.1007/400_2007_049

[7] Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-α in mice [J].

Maida, A. ;

Lamont, B. J. ;

Cao, X. ;

Drucker, D. J. .

DIABETOLOGIA, 2011, 54 (02) :339-349

[8] REDUCED INCRETIN EFFECT IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES [J].

NAUCK, M ;

STOCKMANN, F ;

EBERT, R ;

CREUTZFELDT, W .

DIABETOLOGIA, 1986, 29 (01) :46-52

[9] PRESERVED INCRETIN ACTIVITY OF GLUCAGON-LIKE PEPTIDE-1 [7-36 AMIDE] BUT NOT OF SYNTHETIC HUMAN GASTRIC-INHIBITORY POLYPEPTIDE IN PATIENTS WITH TYPE-2 DIABETES-MELLITUS [J].

NAUCK, MA ;

HEIMESAAT, MM ;

ORSKOV, C ;

HOLST, JJ ;

EBERT, R ;

CREUTZFELDT, W .

JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (01) :301-307

[10] Circulating Ghrelin levels are decreased in human obesity [J].

Tschöp, M ;

Weyer, C ;

Tataranni, PA ;

Devanarayan, V ;

Ravussin, E ;

Heiman, ML .

DIABETES, 2001, 50 (04) :707-709

← 1 2 →